More articles from Editorial

You have access
Highlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumors
Xiaodong Zhang, Chunyu Hou and Guang Yang

Cancer Biology & Medicine February 2022, 19 (2) 133-135; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0533
You have access
A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer
Yuchen Guo, Yangyang Zhou and Wenxin Qin

Cancer Biology & Medicine February 2022, 19 (2) 136-139; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0520
You have access
The emerging role of long noncoding RNA RMRP in cancer development and targeted therapy
Qian Hao and Xiang Zhou

Cancer Biology & Medicine February 2022, 19 (2) 140-146; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0577
You have access
Epigenetic modulation of the tumor immune microenvironment by nanoinducers to potentiate cancer immunotherapy
Ning Zhang and Xishan Hao

Cancer Biology & Medicine January 2022, 19 (1) 1-3; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0514
You have access
Deep proteome profiling promotes whole proteome characterization and drug discovery for esophageal squamous cell carcinoma
Wei Liu, Yongping Cui, Wen Liu, Zhihua Liu, Liyan Xu and Enmin Li

Cancer Biology & Medicine March 2022, 19 (3) 273-277; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0024
You have access
Decoding the intercellular communication network during tumorigenesis
Liwei An, Ruixian Yu, Yi Han and Zhaocai Zhou

Cancer Biology & Medicine March 2022, 19 (3) 265-272; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0558
You have access
Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells
Yunfan Sun, Jian Zhou, Jia Fan and Xinrong Yang

Cancer Biology & Medicine November 2021, 18 (4) 934-936; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0466
You have access
Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian and He Ren

Cancer Biology & Medicine November 2021, 18 (4) 937-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0406
You have access
The role of DLL1 in long-term vascular normalization and cancer immunotherapy
Qiaozhen Wu and Yuhui Huang

Cancer Biology & Medicine November 2021, 18 (4) 940-943; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0507
You have access
Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers
Yingyan Yu

Cancer Biology & Medicine November 2021, 18 (4) 944-948; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0491

Main menu

User menu

Search

More articles from Editorial

Pages

Navigate

More Information

For Authors

Journal Services